Do comparable efficacy & convenient dosing justify Procysbi's extremely high price?
Health Department, Genentech. TMorrow@ManagedCareMag.com
Thomas
T
Morrow
D003543:Cysteamine / Q000008:administration & dosage* / Q000191:economics*; D003554:Cystinosis / Q000188:drug therapy*; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000191:economics; D006801:Humans; D016464:Lysosomal Storage Diseases / Q000188:drug therapy
D003692:Delayed-Action Preparations; D003543:Cysteamine